总时间（秒）：11.92
问答时间（秒）：11.59

```json
[
  {
    "variant_string_id": "EGFR L858R",
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper does not specifically elaborate on the disease mechanism related to EGFR L858R beyond mentioning its role in cancer.",
        "judgment": "Yes",
        "reasoning": "Although not detailed, EGFR is known to be involved in cancer signaling pathways.",
        "next_step_or_outcome": "Proceed to Step 2"
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The paper describes assays that evaluate the function of protein, potentially reflecting disease pathogenesis.",
        "judgment": "Yes",
        "reasoning": "Assays to assess protein function is applicable to investigate the impact of disease-causing variants.",
        "next_step_or_outcome": "Proceed to Step 1a"
      },
      {
        "step_name": "Step 1a: Basic Controls and Replicates",
        "extracted_paper_info": "The paper does not explicitly state the inclusion of both positive and negative controls or mention of replication.",
        "judgment": "No",
        "reasoning": "Lack of statement regarding basic controls/replicates.",
        "next_step_or_outcome": "Proceed to Sub-step 3b"
      },
      {
        "step_name": "Sub-step 3b: Accepted/Validated Assay",
        "extracted_paper_info": "No information is given on whether the assays have been validated in prior work.",
        "judgment": "No",
        "reasoning": "The paper does not include information on prior work.",
        "next_step_or_outcome": "Do not use PS3/BS3"
      }
    ],
    "final_evidence_strength": {
      "type": "N/A",
      "strength": "N/A"
    },
    "overall_conclusion": "Due to a lack of basic controls, replicates, and validation information, the functional data for EGFR L858R cannot be used to assign a PS3/BS3 evidence strength."
  }
]
```